Off-pump coronary artery bypass surgery in selected patients is superior to the conventional approach for patients

Guido Marco Caputti1, José Honório Palma, Diego Felipe Gaia

  • 1Universidade Federal de São Paulo, Cardiovascular Surgery, São Paulo/SP, Brazil.

Clinics (Sao Paulo, Brazil)
|December 23, 2011
PubMed

Insights

Coronary artery bypass grafting without cardiopulmonary bypass (off-pump) is a safe and effective alternative for patients with severe left ventricular dysfunction. Off-pump surgery demonstrated lower mortality and fewer complications compared to traditional cardiopulmonary bypass methods.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Minimally Invasive Cardiac Procedures

Background:

  • Patients with coronary artery disease and severe left ventricular dysfunction face high mortality risks with standard medical management.
  • Coronary artery bypass grafting (CABG) improves survival and quality of life in these patients.
  • Revascularization techniques without cardiopulmonary bypass (off-pump CABG) have emerged as a viable alternative.

Purpose of the Study:

  • To compare the outcomes of CABG performed with cardiopulmonary bypass versus off-pump CABG in patients with left ventricular ejection fractions below 20%.

Main Methods:

  • A nonrandomized study of 217 consecutive patients with ejection fraction ≤20% from January 2001 to December 2005.
  • Patients underwent either conventional CABG with cardiopulmonary bypass (112 patients) or off-pump CABG (105 patients).
  • Demographic, operative, and postoperative data were analyzed.

Main Results:

  • No demographic differences were observed between the groups.
  • Off-pump CABG showed significantly lower mortality (3.8% vs. 12.5%) and fewer postoperative complications.
  • Key improvements with off-pump CABG included shorter hospital and ICU stays, reduced pulmonary complications, less intubation time, decreased bleeding, lower rates of acute renal failure, and better ejection fraction at discharge.

Conclusions:

  • Off-pump CABG is a valid and safe procedure for selected patients with severe left ventricular dysfunction.
  • This technique is associated with reduced mortality and morbidity compared to conventional CABG using cardiopulmonary bypass.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...